Next-Generation mRNA + Nanoparticle Vaccines for Animal Health
From the team that built and sold Harrisvaccines to Merck Animal Health — developing custom, herd-specific livestock vaccines that outpace conventional platforms on speed, scalability, and precision.
Contact Our TeamOur Mission
Deliver faster, more effective vaccines that help protect animal health and strengthen the global food supply.
Innovator of the Year
Leader of the Year
Seed+ Round Closed
Welcome to Genvax Technologies, Inc.
Genvax Technologies is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation mRNA + nanoparticle vaccines. This isn't the first go-around for co-founders Joel Harris and Dr. Hank Harris, who successfully created, grew and sold Harrisvaccines to Merck Animal Health in 2015. We are focused on developing novel vaccines for the prevention and treatment of animal diseases. We cultivate new ideas to make our world a better place and strive to create a long-lasting impact on animal health world-wide. We believe in rapidly responding to the world around us. We are Genvax and we are committed to making the world a better place.